The diagnosis of chronic pancreatitis is hampered by the absence of easily available histological confirmation and is therefore based on morphological and functional variables.`-Direct pancreatic function tests such as the secretin-cholecystokinin or secretin-caerulein test have the highest sensitivity and specificity for the detection of exocrine pancreatic insufficiency and remain the 'gold standard' for testing pancreatic function.3?6 Direct pancreatic function tests, however, have various practical disadvantages: they are time consuming, invasive, expensive, uncomfortable, not standardised, and require fluoroscopic tube placement. Therefore the secretin-caerulein test is unsuitable for routine application and is confined to a few academic centres.
Several simple indirect pancreatic function tests for clinical practice, such as the fluorescein dilaurate test, NBT-PABA or bentiromide test, faecal chymotrypsin determination, or different breath tests, have been established.' 37 However, these proved to have limited sensitivity in mild and moderate exocrine pancreatic insufficiency and are interfered with by some drugs, diarrhoea, pH, and gastrointestinal operations, which lower their specificity. In general these indirect pancreatic function tests are unreliable for clinical practice in early chronic pancreatitiSI-3 5 8 9 and the search continues for a sensitive as well as a practical test to definitely prove or exclude exocrine pancreatic insufficiency.
Recently pancreatic elastase 1 was isolated and further characterised as a human and pancreas specific enzyme that is not degraded during intestinal transport and which is five to sixfold enriched in faeces compared with duodenal juice.'"'2 Furthermore, a highly sensitive enzyme linked immunosorbent assay (ELISA) for human faecal and duodenal elastase 1 determination using two specific monoclonal antibodies is commercially available.'0 1" Early clinical studies gave promising results in patients with exocrine pancreatic insufficiency for determination of faecal elastase 1 concentration in comparison with the fluorescein dilaurate test'3 14 and in a few patients compared with the secretin-caerulein test as well. 15 16 The aim of the present study was to evaluate (a) the sensitivity and specificity of faecal elastase 1 determination in a sufficient number of patients with exocrine pancreatic in- (Fig 1) . of 100 pug/g stool and 200 j.g/g stool and faecal chymotrypsin activity with a cut off of 3 UIg.
Faecal elastase concentrations below 200 Ug/g stool show a total of 93% both for sensitivity and specificity, whereas sensitivity for moderate and severe exocrine pancreatic insufficiency is 1 00% and for mild insufficiency 63%. By comparison with mild and moderate insufficiency the sensitivity of faecal chymotrypsin amounted to 25% and 50% respectively (Table II) . Linear regression analysis showed significant correlations between duodenal as well as faecal elastase concentrations and duodenal trypsin, lipase, amylase, total volume, and bicarbonate 27 .52%, 10.37%, and 17.15% after storage of the stool samples for one week. Discussion Elastase 1 is a proteolytic pancreas specific enzyme with a molecular weight of about 28 kDa with a special affinity to the carboxyl group of alanine, valine and leucine.10 13 It was first described in 1975 by Mallory and Travis23 as protease F, and further characterised as an elastolytic pancreatic enzyme by Largmann et al. 24 Under physiological conditions elastase 1 concentration in pancreatic juice is between 170 and 360 ,ug/ml, which is about 6% of all secreted pancreatic enzymes.25 During intestinal passage elastase 1 is mainly bound to bile salts and it was shown that elastase 1 -by contrast with other pancreatic enzymes -is not degraded during passage through the gut, whereas it is concentrated about five to sixfold in human faeces compared with pancreatic juice10 12 25 Recently published studies comparing faecal elastase 1 concentration with the fluorescein dilaurate test and faecal chymotrypsin activity in patients with chronic pancreatitis disclosed a comparable sensitivity of faecal elastase 1 Significant correlations between faecal as well as duodenal elastase 1 concentrations and duodenal lipase, amylase, trypsin, volume, and bicarbonate were found, which proves that secretion patterns of elastase are similar to those of other pancreatic enzymes. Furthermore, faecal elastase 1 was highly significantly correlated to duodenal elastase 1 concentrations, which clearly confirms the suggestions of other investigators that measurement of faecal elastase 1 is representative of pancreatic elastase 1 secretion.°2 5 This study disclosed very low individual day to day variations of faecal elastase 1 concentrations, confirming results of studies in children with cystic fibrosis.26 Faecal elastase 1 determination does not require analysis of different stool samples as a single analysis of a normal 100 mg stool sample proved to be sufficient and should only be repeated in uncertain cases with faecal elastase 1 concentrations in the borderline area around 200 ,ug/g stool. Furthermore, faecal elastase 1 was found to be stable over a storage period of one week, even at room temperature, as also described by other investigators28 and this makes handling and even mailing of a small stool sample straightforward and easy. As monoclonal antibodies against human pancreatic elastase are used in the ELISA kit,'°11 faecal elastase 1 determination is not affected by simultaneous enzyme replacement therapy with pancreatin of animal origin. 28 In conclusion, the data of the present study show the excellent sensitivity of faecal elastase 1 determination for moderate and severe exocrine pancreatic insufficiency and its limited sensitivity for mild disease. At present faecal elastase 1 determination is the most sensitive and specific tubeless pancreatic function test available, and furthermore proved to be a rapid and easy to handle routine method.
